GALR3


Galactoslyceramidase 3 (GALR3): A Key Enzyme in Lysosomal Lipid Metabolism

Description

Galactosylceramidase 3 (GALR3) is an enzyme that plays a critical role in the lysosomal metabolism of glycosphingolipids, a class of lipids found in the membranes of cells. Glycosphingolipids are essential for proper cell function, but their accumulation can lead to a range of diseases. GALR3 is responsible for the degradation of galactosylceramide, a glycosphingolipid that is abundant in the myelin sheath of neurons.

Associated Diseases

Mutations in the GALR3 gene can lead to lysosomal storage disorders, including:

  • Gaucher disease: The most common lysosomal storage disorder, characterized by the accumulation of glucosylceramide in macrophages and other cells.
  • Krabbe disease: A fatal neurodegenerative disorder caused by the accumulation of psychosine in the central nervous system.
  • Metachromatic leukodystrophy: Another neurodegenerative disorder resulting from the accumulation of sulfatides in the brain and spinal cord.

Did you Know ?

One in 40,000 to 60,000 people worldwide is affected by Gaucher disease, making it the most prevalent lysosomal storage disorder.



Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.